RepliCel Life Sciences (TSE:RP) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
RepliCel Life Sciences is urging shareholders to access its management information circular online due to possible postal delays caused by a Canada Post labor disruption. The company is preparing for a critical shareholders meeting to discuss the sale and licensing of its assets and potential delisting.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.